Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | CytomX Therapeutics, Inc. CTMX | RA Capital Management, L.P. | 0 0.000% | -3,500,000 (Position Closed) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Tango Therapeutics, Inc. TNGX | RA Capital Management, L.P. | 2,250,000 2.600% | 2,250,000 (New Position) | Filing History |
| 2022-02-14 4:11 pm Unchanged | 2021-12-31 | 13G | Akouos, Inc. AKUS | RA Capital Management, L.P. | 2,281,249 6.600% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:11 pm Unchanged | 2021-12-31 | 13G | BCLS Acquisition Corp. BLSA | RA Capital Management, L.P. | 1,250,000 8.400% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:11 pm Unchanged | 2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN | RA Capital Management, L.P. | 2,805,045 5.400% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:11 pm Unchanged | 2020-12-31 | 13G | 5:01 Acquisition Corp. FVAM | RA Capital Management, L.P. | 750,000 8.700% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | GH Research PLC GHRS | RA Capital Management, L.P. | 2,843,757 5.500% | -135,198 (-4.54%) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX | RA Capital Management, L.P. | 2,613,623 5.300% | 2,613,623 (New Position) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | RA Capital Management, L.P. | 3,510,103 9.990% | 1,686,583 (+92.49%) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Geron Corporation GERN | RA Capital Management, L.P. | 32,388,799 9.990% | 1,273,858 (+4.09%) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | RA Capital Management, L.P. | 2,246,503 7.500% | -81,211 (-3.49%) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | Frazier Lifesciences Acquisition Corporation FLAC | RA Capital Management, L.P. | 0 0.000% | -1,000,000 (Position Closed) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | ImmunoGen, Inc. IMGN | RA Capital Management, L.P. | 22,162,958 9.990% | 3,745,500 (+20.34%) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | Novavax, Inc. NVAX | RA Capital Management, L.P. | 2,097,794 2.800% | -1,690,770 (-44.63%) | Filing History |
| 2022-02-14 4:11 pm Unchanged | 2021-12-31 | 13G | ARS Pharmaceuticals, Inc. SPRY | RA Capital Management, L.P. | 1,742,186 4.970% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | RA Capital Management, L.P. | 0 0.000% | -388,385 (Position Closed) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | CYTEIR THERAPEUTICS INC CYTT | RA Capital Management, L.P. | 3,350,506 9.500% | 103,389 (+3.18%) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | RA Capital Management, L.P. | 1,930,322 7.900% | 530,833 (+37.93%) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | RA Capital Management, L.P. | 1,334,610 7.500% | -180,541 (-11.92%) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Verona Pharma plc VRNA | RA Capital Management, L.P. | 48,778,172 9.990% | 7,235,168 (+17.42%) | Filing History |